Sunday, April 27, 2008

Study: Bunnies and BAC, and why we should care!

OK so we already know that BAC (BAK) is bad bad stuff for the corneas, but the problem is, it's still out there in nearly all commonly prescribed ophthalmic medications including most glaucoma drops.

And while I'm on the subject... if you want to know how much is in the drops you are prescribing or have been prescribed, please visit our preservative reference list.

So along comes this lovely new rabbit model showing how JUST TWO WEEKS of BAC twice daily in a concentration just 5x what's in Xalatan did ALL of the following:
- caused dry eye syndrome
- damaged the cornea and conjunctiva
- decreased aqueous tear basal secretion and
- caused goblet cell loss and MUC5AC deficiency

I sure hope the glaucoma docs are following this literature carefully and prescribing accordingly.

A Rabbit Dry Eye Model Induced by Topical Medication of a Preservative Benzalkonium Chloride.
Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, Wang Z.
Invest Ophthalmol Vis Sci. 2008 May;49(5):1850-1856

PURPOSE: To establish a rabbit dry eye model with topical medication of the ocular preparation preservative benzalkonium chloride (BAC). METHODS: Sixteen white rabbits were used. One eye of each rabbit was chosen randomly for topical administration of 0.1% BAC twice daily for 14 days. The other untreated eyes served as controls. Schirmer test, fluorescein, and rose bengal staining were performed before and after BAC treatment on days 3, 5, 7, and 14. Conjunctiva impression cytology specimens were collected on days 0, 7, and 14. The rabbits were killed after day 14. Immunofluorescence staining was performed to detect mucin-5 subtype AC (MUC5AC) on conjunctival cryosections. Cornea and conjunctiva structures were evaluated by light and electron microscopy. RESULTS: Compared with untreated controls, BAC-treated eyes showed significant decreases in Schirmer scores (P = 0.01) and increases in fluorescein scores (P < 0.001) on days 5, 7, and 14. A significant increase in rose bengal scores was noticed as early as day 3 (P = 0.001). Decreases in goblet cell density occurred on days 7 and 14 (P = 0.001). Decreased MUC5AC and histopathologic and ultrastructural disorders of the cornea and conjunctiva were also observed in the BAC group. CONCLUSIONS: These findings demonstrated that an ophthalmic preservative, benzalkonium chloride, induced a dry eye syndrome in rabbits with damage to the cornea and conjunctiva, decreased aqueous tear basal secretion, goblet cell loss, and MUC5AC deficiency. This rabbit model was consistent with human dry eye syndrome in both aqueous tear and mucin deficiency and may be appropriate for studying dry eye syndrome.

No comments: